ggggg
Welcome!
Here you’ll find the latest funding opportunities available to support your work.
Each listing includes a brief overview and a direct link to full details, including eligibility, deadlines, and how to apply.
If you have any questions, don’t hesitate to contact us — we are happy to help.
Good luck with your application!
qqqq
——————————————————————————————————
Eureka & European Union – European Partnership on Innovative SMEs
Call 9 of EUROSTARS-3 – September 2025
Scope:
– Part of the European Partnership on Innovative SMEs, Eurostars is a funding instrument that supports innovative SMEs and project partners (large companies, universities, research organisations and other types of organisations) by funding international collaborative R&D and innovation projects. By participating, organisations can access public funding for international collaborative R&D projects in all fields.
– The innovative SME must lead the project consortium.
– To have a successful Eurostars application you must define your project idea, collaborate internationally & sharing expertise, and develop innovative products, processes or services that can be easily commercialised. First, you must contact your national funding body using the Eureka website form.
Application Deadline: 4 September 2025 at 14:00 Brussels time, submission on myeurekaproject.org (create an account).
Funding amount: Your national funding body will disclose the available amount.
Grant Duration: up to 36 months (possible extension).
Eligibility:
– Consortium led by innovative SME from a Eurostars country.
– Consortium of at least 2 entities (independent from each other), from at least 2 Eurostars countries with at least one from an EU or EU-Associated country.
– Budget of SME should be at least 50% of total project cost (no single participant or country responsible for >70% of total budget).
Practical info:
– Downloaded Call information: Call for proposals (PDF)
– See Guidelines, Forms and FAQs
Check it out: Call for proposals
Eureka Network Projects
Eureka LinkUp call for projects: connecting regions for innovation
For startups/organisations in Austria, Albania, Montenegro, Serbia, Slovenia, Türkiye
Scope:
– Ministries and funding agencies in Albania (NASRI), Austria (FFG), Montenegro (Ministry of Education, Science and Innovation), Serbia (NITRA), Slovenia (MHESI) and Türkiye (TÜBITAK) have funding for international cooperation between organisations collaborating on R&D projects, i.e. R&D of an innovative product, process or service with the goal of commercialisation, in all thematic areas or application domains.
International Application Deadline: 10 September 2025. Submission on SmartSimple application platform (create an account).
National Application Deadlines: check the websites of your national funding agency: see “Applying” section from Call for proposals below. Parallel submission is mandatory on the respective national funding agencies’ platforms of participants.
Funding amount: Refer to your national funding agency for the available amount.
Grant Duration: up to 36 months (check your national funding agency’s website).
Eligibility:
– Your R&D project must include at least two organisations based in at least two of the countries participating in this Network projects call for projects.
– The project must have a civilian purpose.
– No single participant or country can be responsible for >70% of total project budget.
– See additional eligibility requirements from the participants’ national funding agencies.
Practical info:
– First, contact your national funding body using the Eureka website form.
– Eureka national funding agencies
– Downloaded Call information: Call for proposals (PDF)
– How to use the SmartSimple application platform
Check it out: Call for proposals
Defence Innovation Accelerator of the North Atlantic (DIANA)
DIANA Challenge Call
Scope:
– The DIANA accelerator Programme issues ‘challenges’ through Challenge Calls to identify emerging and disruptive technologies which can fulfil capability needs of the Alliance countries.
– One of the challenges is: Human Resilience and Biotechnologies. DIANA seeks cutting-edge biomedical, biotechnology, bioengineered, synthetic and computational solutions to protect the wellbeing and security of NATO citizens and military personnel. Listed among the potential solutions: “New therapeutic agents and tools to combat multi-drug-resistant organisms, anti-microbial resistance and associated infections, sepsis and complications.”
– DIANA focuses on dual-use technologies, i.e. that have applications in both civilian and defence & security settings. It does not work on weaponry, munitions etc.
Application Deadline: 11 July 2025 at 12:00 GMT/UTC, submission on DIANA’s Challenge Portal (registration for log in account).
Funding amount:
– Accelerator Programme Phase 1: €100,000 of contractual funding to support ongoing development of proposed solution and to cover innovators’ travel costs for mandatory training sessions and events of the Programme.
– Accelerator Programme Phase 2: after completion of Phase 1, top performers eligible for up to an additional €300,000.
Grant Duration: 6 months (Phase 1)
Eligibility:
– Any single incorporated company with its principal place of business in a NATO member nation, controlled and majority owned by nationals of NATO member nations.
– Collaborative proposals from several companies also accepted if all member companies meet eligibility requirements. One single company must be the lead.
– DIANA seeks technology solutions at TRL 4-7 but lower TRL solutions offering significant strategic impact and higher TRL solutions that could be adapted to defence and security applications will be considered.
– University and non-profit groups are NOT eligible to apply.
Practical info:
• See FAQs
Check it out: HERE
ENABLE-2
Open Call for new antibiotic programmes: Hit validation and Hit to Lead
Scope:
– ENABLE-2 is an interdisciplinary team of international experts guiding researchers with early-stage antibacterial programmes. It has built an antibacterial drug discovery platform with focus on the early stages of antibiotic discovery and development. ENABLE-2 aims to fill a gap, feeding the early pipeline of new antibiotics, to ensure a sustainable flow of new antibacterial drug candidates into the development pipeline.
– Two entry levels to apply for: ENABLE-2 Incubator-Hit validation and ENABLE-2 Hit to Lead.
– ENABLE-2 funding is non- dilutive. Successful applicants retain ownership of all data generated, IP right to any new compounds developed.
Hit validation programme:
– Novel compounds with some documented whole cell antibacterial activity against any species or strain, with a MIC of at least 32 µg/mL, or
– Novel compounds with only documented bacterial target activity.
– Potential for development as direct-acting antibiotics for systemic use.
– Not previously reported to have antibacterial activity.
– Antimicrobial peptides with only membrane perturbation activity are not eligible.
– Novel natural products are eligible.
Application deadline: call open continuously, submission of Expression of Interest (EOI) to opencall.enable2@ilk.uu.se
Funding amount: ENABLE-2 offers evaluation of the antibiotic potential of novel compounds.
Check it out: ENABLE-2 Incubator – Hit validation
Hit to Lead programme:
– Novel Hit compounds with wild-type whole cell antibacterial activity and the potential for development as direct-acting antibiotics for systemic use.
Application deadline: The call is open continuously but to be considered for entry at the next Portfolio Management Committee (PMC) meeting in October, applications should reach us by 12 September 2025. Expression of Interest (EOI) to opencall.enable2@ilk.uu.se
Funding amount: ENABLE-2 offers expert advice, access to experimental platforms, funding to carry out approved assays, not available within the platform, at CROs.
Check it out: ENABLE-2 Hit to Lead
Eligibility:
– All researchers at publicly funded universities and research institutes in Europe (including non-EU countries such as UK, Norway, Switzerland, etc.)
– For Hit to Lead call, check additional requirements for the compounds on the call page above.
Practical info: Contact: Prof. Anders Karlén, Coordinator – anders.karlen@ilk.uu.se
European Commission – Horizon Europe
Boosting the translation of biotech research into innovative health therapies (HORIZON-HLTH-2025-01-TOOL-05)
Research & Innovation Action (Collaborative Grant)
Scope:
– Speed up the development of innovative biotechnology-based therapies by supporting the initial phases of clinical research.
A non-exhaustive list of biotechnology-derived therapies in scope include monoclonal antibodies, (therapeutic) vaccines, recombinant biomolecules, Advanced Therapy Medicinal Products (ATMPs), nano-based drugs, RNA therapies etc. Whole blood, blood components and other substances of human origin are NOT within the scope of this topic.
Proposals should include:
– A Clinical study either phase I, II or I/II depending on the appropriate stage of development
– A demonstration of a significant economic potential of the final product(s) for the Single Market.
– A clearly defined exploitation plan with a detailed proposed route to commercialisation, description of the IP ownership and benefit for the SME(s).
– Justification of the patient populations that will benefit directly from the development of
the therapies.
Application deadline: 16 September 2025 17:00 Brussels time
Funding amount: ~ EUR 4 – 8 million/granted project
Eligibility: EU, non-EU countries (check General Annexes, also in Call link below). This topic targets collaborative multidisciplinary consortia of SMEs, academics, clinicians and research organisations bringing together the necessary expertise to launch the clinical development of novel biotechnology-derived therapeutics.
Find partners for your project consortium: Find project partners
Practical info:
• grants@unibas.ch for Unibas groups
• https://www.euresearch.ch/ for Swiss-based groups | startups
• National Contact Points for Horizon Europe for other countries
Check it out: Call for Proposals
European Commission – Horizon Europe
Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) (HORIZON-HLTH-2025-01-TOOL-03)
Research & Innovation Action (Collaborative Grant)
Scope:
– This topic aims to advance research and provide new evidence on how novel generative AI models contribute to and support biomedical research and its applicability towards more predictive and personalised medicine, while also defining use conditions, usability requirements and training needs of the researchers. It aims to cover existing gaps related to Generative AI in biomedical research, addressing both capabilities and existing limitations.
Proposals should include:
– Development of new or repurposing of existing Generative AI models for biomedical research across various medical fields and/or therapeutic indications.
– Development of a proof of concept with at least two use cases relevant for predictive and personalised medicine in different medical fields to demonstrate the scientific added value compared to currently used methods and/or potential future clinical utility of the Generative AI models in biomedical research.
– Development or revision of existing methodologies to assess alignment with human values and the use cases of developed and/or repurposed Generative AI models, their applicability, performance, limitations and added value in biomedical research. These methodologies should demonstrate the technical, scientific, and potential future clinical utility, robustness and trustworthiness of the developed or repurposed Generative AI models
Application deadline: 16 September 2025 17:00 Brussels time
Funding amount: ~ EUR 15 – 17 million/granted project
Eligibility: EU, non-EU countries, USA (check General Annexes, also in Call link below). Research actions under this topic should ensure multidisciplinary approaches and a broad representation of stakeholders in the consortia (e.g. EU industrial developers of Generative AI solutions including leading-edge startups, academia, healthcare professionals)
Find partners for your project consortium: Find project partners
Practical info:
• grants@unibas.ch for Unibas groups
• https://www.euresearch.ch/ for Swiss-based groups | startups
• National Contact Points for Horizon Europe for other countries
Check it out: Call for Proposals
European Commission – Horizon Europe
Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
(HORIZON-HLTH-2025-01-IND-01)
Innovation Action (Collaborative Grant)
Scope:
– The topic focuses on addressing the challenges of ATMP manufacturing, the need for highly specialised equipment and facilities, including in-process quality control and validation tests, scaling up and batch-to-batch reproducibility.
– This topic aims to optimise the ATMP production where the general manufacturing process for a given medicinal product has already been established but has not been sufficiently optimised for its scale-up.
Proposals should include:
– Design an improved manufacturing process for ATMPs
– Verify the improved performance of the developed process, in comparison to established ones.
– Demonstrate a reduction in the timeframe and costs of manufacturing while maintaining product quality and standardisation.
– Demonstrate the translatability, scalability, and robustness of the process suitable for the flexible manufacturing and deployment of ATMPs by important stakeholders in a patient-centric manner.
– Assess the process and methods developed for their regulatory validity and utility.
– Promote green and sustainable industrial production and minimise environmental impact.
Application deadline: 16 September 2025 17:00 Brussels time
Funding amount: ~ EUR
6 – 8 million/granted project
Eligibility: EU, non-EU countries, USA (check General Annexes, also in Call link below). Participation of small and medium-sized enterprises (SMEs) is strongly encouraged and proposals should include a commitment for first deployment in the EU
Find partners for your project consortium: Find project partners
Practical info:
• grants@unibas.ch for Unibas groups
• https://www.euresearch.ch/ for Swiss-based groups | startups
• National Contact Points for Horizon Europe for other countries
Check it out: Call for Proposals
European Commission – Horizon Europe
EIC Transition Open 2025:
HORIZON-EIC-2025-TRANSITIONOPEN
Scope:
– EIC Transition (EIC Work Programme 2025, page 51-61) funds innovation activities that go beyond the experimental proof of principle in laboratory. It supports both the maturation and validation of your novel technology from the lab to the relevant application environments (by making use of prototy#ping, formulation, models, user testing or other validation tests), and explorations and development of a sustainable business case and business model towards commercialisation. It therefore funds projects from TLR 3-4 to reach TLR 5-6.
– Your proposal must build on results already achieved within an eligible EU-funded project that are, at least, at experimental proof of concept (see Excel list of eligible EU-funded projects in attachment).
– You can apply for an EIC Transition project to further develop the results created by someone else (another project where your legal entity did not participate) – EIC Work Programme 2025, page 54: If you (applicant(s) eligible for funding) were not part of the eligible project whose results are further developed in the EIC Transition proposal, you (the applicant/coordinator) need to include in your proposal a commitment letter from the owner(s) of the relevant result(s), which confirms the commitment of the latter to negotiate with you fair, reasonable and non-discriminatory access to such results, including IPR, for the purpose of future commercial exploitation for the whole duration of the EIC Transition project.
You can apply as (see EIC Work Programme 2025, page 55) :
– A single legal entity
– A small consortium of two independent legal entities or
– A consortium of minimum three and maximum five independent legal entities (multi-beneficiary’) following standard rules.
The legal entities may for example be a start-up, an SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors in such institutions who intend to form a spinout company).
Application deadline: 17 September 2025 17:00 Brussels time
Funding amount: EUR 0.5 to 2.5 million/granted project
Grant Duration: 1 to 3 years
Eligibility: EU, non-EU countries, USA (check General Annexes and Annex 2 of EIC Work Programme 2025, also in Call link below). Single applicants (SMEs, spin-offs, start-ups, research organisations, universities) or small consortia (minimum 2, maximum 5 eligible entities).
Practical info:
• grants@unibas.ch for Unibas groups
• https://www.euresearch.ch/ for Swiss-based groups | startups
• National Contact Points for Horizon Europe for other countries
Check it out: Call for proposals
European Commission – Horizon Europe
EIC Accelerator 2025 – Short application:
HORIZON-EIC-2025-ACCELERATOR-01
Short application of two-stage application
Scope:
– The EIC Accelerator ‘Grant Only’ (EIC Work Programme 2025, page 62-80) funds startups and SMEs for innovation activities of TLR6 to TLR8. It supports the later stages of development.
– The ‘Grant only’ component is non-dilutive and takes the form of a lump sum contribution via a grant agreement. ‘Grant only’ shall be provided under the following cumulative conditions:
– the project shall include information on the capacities and willingness of the applicant to scale-up;
– the beneficiary shall be a start-up or an SME;
– the ‘Grant-only’ support shall be provided only once to a beneficiary during the period of implementation of the Horizon Europe programme (2021-2027)
Deadline for short application: Anytime (continuous)
Deadline for full application (if notification of successful short application in 2025):
1st October 2025 or any of the cut-off dates for 2026 (these will be announced in the 2026 Work Programme).
Funding amount for ‘Grant only’: Up to EUR 2.5 million/granted project (= max 70% total eligible costs)
Grant Duration: 24 months
Eligibility:
– EU & Associated countries.
– Third countries (ex: Switzerland, UK) if they establish/relocate their company to an EU or Associated country, which must be done before submission of full application.
– Standard admissibility & eligibility in Annex 2 of EIC Work Programme 2025 (also in Call link below).
– You can apply for the ‘Grant only’ component as (see EIC Work Programme 2025, page 63):
– A Single start-up or SME (including spin-outs)
– Individuals intending to establish an SME
Practical info:
• EIC Accelerator and Guide for Applicants
• grants@unibas.ch for Unibas groups
• https://www.euresearch.ch/ for Swiss-based groups | startups
• National Contact Points for Horizon Europe for other countries
Check it out: Call for proposals
Novo Nordisk Foundation
Challenge Programme 2026: Unravelling the pathways of human invasive fungal diseases
Scope:
The Challenge Programme aims to support highly ambitious and collaborative projects that are transformative and impactful in their aim to generate important new knowledge about human invasive fungal diseases and enable the development of better diagnostics and therapeutics.
Research topics may include (not limited to):
– Elucidating the role of fungal virulence factors
– Studying host-pathogen interactions
– Understanding mechanisms of anti-fungal resistance
– Advancing fungal disease markers
Application deadline: Stage 1: 8 October 2025 2:00pm (CET); Stage 2: 4 February 2026 2:00pm (CET)
Register and submission to grant management system NORMA
Funding amount: ~ DKK 40 – 75 million/granted project (~ EUR 5.4 – 10 million)
Grant duration: 6 years
Eligibility:
– Collaborative consortium of 2-4 research groups.
Main applicant:
– Tenured/tenured track researcher and own research group from European Union, Schengen Area, UK
– From University, Hospital, Non-Profit Organisation
– Employed at host institution with at least 75% commitment with own salary guaranteed
Co-applicants: from anywhere else globally.
– At least one applicant (either main- or co-applicant) must be at least 75% employed and have their research group at a Danish university, hospital, or non-profit research organisation.
– Industry collaboration is allowed but industrial partners cannot receive funding.
Practical info:
• Guidelines for applicants
• FAQs
• Contact: challenge@novo.dk
Check it out: Call for proposals
European Cooperation in Science & Technology
COST Actions Open Call
Scope:
– COST is a pan-European intergovernmental framework dedicated to supporting European-based Science and Technology (S&T) networking activities, enabling collaboration between researchers, innovators, and other relevant stakeholders. COST participants can jointly develop ideas and new initiatives across all scientific disciplines through trans-European coordination of nationally or otherwise funded research activities.
– The research and development activities needed for the achievement of the Action objectives are NOT funded by COST and rely on nationally or otherwise funded research projects and resources (e.g., employees’ time, infrastructures and equipment). The COST Action funding covers the expenses of NETWORKING ACTIVITIES rather than research. As such is used to organise and fund events, Short-term Scientific Missions, Training Schools, communication activities, grants to attend interesting international conferences, and virtual networking tools. Funding Networking Activities
Application Deadline: 21 October 2025 at 12:00 (noon) CEST, submission on e-COST
Funding amount: ~ €125,000 in first year, €150,000 per year for the other three (variable depending on the number of COST Countries represented in the Working Groups).
Grant Duration: 4 years
Eligibility:
– Switzerland, EU member states, non-EU member states. As per COST Countries and Organisations Table
– You can apply as: Researchers and innovators from universities, from public and private institutions, NGOs, industry and SMEs – all institutions are welcome.
– It must be a network of at least 7 applicants from different COST Full or Cooperating Member countries including at least 50% from COST Inclusiveness Target Countries. As per COST Countries and Organisations Table
Practical info and guidance:
• All Open Call application Documents & Guidelines
• COST National Coordinators for all eligible countries.
• grants@unibas.ch for Unibas groups.
Check it out: Call for proposals
